LYRA - Lyra Therapeutics  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LYRA is currently covered by 1 analysts with an average price target of $11.82. This is a potential upside of $5.99 (102.74%) from yesterday's end of day stock price of $5.83.

Lyra Therapeutics 's activity chart (see below) currently has 1 price targets and 5 ratings on display. The stock rating distribution of LYRA is 100% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66.67% with an average time for these price targets to be met of 472.17 days.

Highest price target for LYRA is $16, Lowest price target is $16, average price target is $16.

Most recent stock forecast was given by MATTHEW CAUFIELD from HC WAINWRIGHT on 14-Aug-2025. First documented stock forecast 26-May-2020.

Best performing analysts who are covering LYRA - Lyra Therapeutics :

Jason Gerberry Robert Hazlett Matthew Caufield Louise Chen Dennis Ding Justin Zelin

Currently out of the existing stock ratings of LYRA, 3 are a HOLD (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$16

$9.63 (151.18%)

$16

2 months 16 days ago
(14-Aug-2025)

0/3 (0%)

$8.9 (125.35%)

Buy

1 years 2 months 15 days ago
(15-Aug-2024)

1/1 (100%)

$9 (150.00%)

1105

Hold

$10

$3.63 (56.99%)

1 years 5 months 23 days ago
(07-May-2024)

1/1 (100%)

$-11 (-52.38%)

190

Hold

$15

1 years 5 months 24 days ago
(06-May-2024)

1/1 (100%)

$11.36 (312.09%)

605

Buy

$10

$3.53 (54.56%)

$11

1 years 5 months 28 days ago
(02-May-2024)

6/6 (100%)

$5.37 (115.98%)

933

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LYRA (Lyra Therapeutics ) average time for price targets to be met?

On average it took 472.17 days on average for the stock forecasts to be realized with a an average price target met ratio 66.67

Which analyst has the current highest performing score on LYRA (Lyra Therapeutics ) with a proven track record?

JASON GERBERRY

Which analyst has the current lower performing score on LYRA (Lyra Therapeutics ) with a proven track record?

JUSTIN ZELIN

Which analyst has the most public recommendations on LYRA (Lyra Therapeutics )?

Jason Gerberry works at BAML and has 5 price targets and 3 ratings on LYRA

Which analyst is the currently most bullish on LYRA (Lyra Therapeutics )?

Matthew Caufield with highest potential upside - $9.63

Which analyst is the currently most reserved on LYRA (Lyra Therapeutics )?

Robert Hazlett with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?